In this prospective, randomized, multicentric phase 3 trial the authors concluded that PSMA-PET imaging had a 27% higher accuracy in the detection of PCa lesions compared to conventional imaging (92% vs. 65%, p < 0.001) [1]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.